Skip to content

Clinical trials

Adenocarcinoma of Lung trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Country / region: South Korea Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20111
20124
20134
20151
20161
20171
20181
20194
20201
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status6
Terminated5
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Samsung Medical Center3
National Cancer Center, Korea2
Turning Point Therapeutics, Inc.2
Amgen1
AstraZeneca1
Bayer1
Cancer Therapeutics Research Group1
Celltrion1
Konkuk University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung25
Carcinoma, Non-Small-Cell Lung15
Lung Neoplasms13
Neoplasm Metastasis4
Adenocarcinoma, Bronchiolo-Alveolar3
Neoplasms2
Adenocarcinoma1
Carcinoma, Medullary1
Carcinoma, Ovarian Epithelial1
Cholangiocarcinoma1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.